X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
GSK Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK Pharma Quarterly Results   (GLXO)

Here are the latest quarterly results of GSK Pharma. For more details, see the GSK Pharma financial fact sheet and GSK Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

GSK Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-16
3
Dec-16
3
Mar-17
*
3
Jun-17
3
Sep-17
3
Dec-17
3
Mar-18
3
Jun-18
8-Qtr Chart
Click to enlarge
Net Sales Rs m7,9917,0647,8376,0718,3637,0397,4867,357 
Other income Rs m18114814913796120183178 
Turnover Rs m8,1727,2127,9866,2088,4597,1597,6697,534 
Expenses Rs m6,5826,3646,4695,8746,4425,6215,9385,953 
Gross profit Rs m1,4097001,6263231,9731,4181,5491,321 
Depreciation Rs m666678757713494114 
Interest Rs m00000022 
Profit before tax Rs m1,5247821,6973851,9911,4041,6361,383 
Tax Rs m536252570120688507581497 
Profit after tax Rs m9895301,1272641,3038971,056886 
Gross profit margin %17.69.920.75.323.620.120.718.0 
Effective tax rate %35.132.333.631.334.636.135.535.9 
Net profit margin %12.47.514.44.415.612.714.112.0 
Diluted EPS Rs 5.8 3.1 6.7 1.6 7.7 5.3 6.2 5.2  
Diluted EPS (TTM) Rs 21.1 19.5 19.9 17.2 19.0 21.2 20.8 24.4  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: GSK Pharma 1QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   MERCK LTD  INDRAPRASTHA MEDICAL  CIPLA  PFIZER  INDOCO REMEDIES  

Compare GSK PHARMA With:   MERCK LTD  INDRAPRASTHA MEDICAL  CIPLA  PFIZER  INDOCO REMEDIES  

Compare GSK PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Over 450 Points Lower; IT and Energy Stocks Witness Selling(Closing)

Share markets in India continued their sell-off seen during the day and ended the trading session deep in the red. All sectoral indices traded on a negative note with stocks in the IT sector.

Views on news

GSK PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 235.3% (Quarterly Result Update)

Jul 26, 2018 | Updated on Jul 26, 2018

For the quarter ended June 2018, GSK PHARMA has posted a net profit of Rs 886 m (up 235.3% YoY). Sales on the other hand came in at Rs 7 bn (up 21.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (4QFY18); Net Profit Down 6.4% (Quarterly Result Update)

May 28, 2018 | Updated on May 28, 2018

For the quarter ended March 2018, GSK PHARMA has posted a net profit of Rs 1 bn (down 6.4% YoY). Sales on the other hand came in at Rs 7 bn (down 4.5% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

You Can Buy Select Auto Stocks Now for Big Long-Term Returns(The 5 Minute Wrapup)

Oct 17, 2018

Irrespective of the earnings hiccups, these businesses be setting new profit records.

This Market Crash could be the Biggest Wealth Creating Opportunity Since 2008(Profit Hunter)

Oct 8, 2018

While widespread fear is the friend of a value investor, serving up bargain purchases; personal fear is an investor's biggest enemy.

IPO Market Feels the Heat of the Market Crash(Sector Info)

Oct 12, 2018

The sentiments in primary market have also deteriorated amid the stock market correction. Most listed IPOs of 2018 are trading below their issue price.

Even If IL&FS Group Brought This Correction, this is Right Time to Buy & Sit Tight!(Chart Of The Day)

Oct 12, 2018

Even if IL&FS is the culprit, it may turn out to be a hero if you buy right and sit tight.

ICICI Prudential Manufacture In India Fund: A Make In India Prodigy, Should You Invest?(Outside View)

Oct 8, 2018

PersonalFN briefly explains if you should be investing in the NFO: ICICI Prudenetial Manufacture in India Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Oct 19, 2018 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GSK PHARMA

GSK PHARMA - ACTAVIS COMPARISON

COMPARE GSK PHARMA WITH

MARKET STATS